Here, we report a new patient with APLAID caused by a unique activating mutation in PLCγ2 that presented with novel manifestations, including cutis laxa and sensorineural deafness. This evidence concerns the gene PLCG2 and autoinflammation-PLCG2-associated antibody deficiency-immune dysregulation.